Sebacic Acid

Sebacic Acid

SCHEMBL7053744

C=CC.O=C(O)CCCCCCCCC(=O)O.O=C(O)CCCCCCCCC(=O)O.O=C(O)CCCCCCCCC(=O)O.O=C(O)CCCCCCCCC(=O)O.O=C(O)CCCCCCCCC(=O)O.O=C(O)CCCCCCCCC(=O)O.O=C(O)CCCCCCCCC(=O)O.O=C(O)CCCCCCCCC(=O)O.O=C(O)CCCCCCCCC(=O)O

nearest known ligand 0.67

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 5/20 0.67
LMNA P02545 2/20 0.67
NFKB1 P19838 1/20 0.67
PMP22 Q01453 1/20 0.67
ABCC4 O15439 1/20 0.65
MAPT P10636 1/20 0.65
GPR84 Q9NQS5 8/20 0.59
PPARG P37231 7/20 0.59
PPARD Q03181 7/20 0.59
PPARA Q07869 7/20 0.59
HDAC11 Q96DB2 5/20 0.59
PTPN1 P18031 3/20 0.59
ALDH1A1 P00352 2/20 0.59
TLR2 O60603 2/20 0.59
TDP1 Q9NUW8 2/20 0.59
FABP4 P15090 2/20 0.59
FFAR1 O14842 2/20 0.59
FFAR4 Q5NUL3 2/20 0.59
SLC22A6 Q4U2R8 1/20 0.59
SLC22A8 Q8TCC7 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Azelaic Acid SCHEMBL8711298 1.00 TSHR (0.67) TSHRLMNANFKB1PMP22ABCC4
Sebacic Acid SCHEMBL7057259 1.00 TSHR (0.67) TSHRLMNANFKB1PMP22ABCC4
Sebacic Acid SCHEMBL1046750 1.00 TSHR (0.67) TSHRLMNANFKB1PMP22ABCC4
Propene SCHEMBL7054981 1.00 TSHR (0.67) TSHRLMNANFKB1PMP22ABCC4
Sebacic Acid SCHEMBL7053358 1.00 TSHR (0.67) TSHRLMNANFKB1PMP22ABCC4
Propene SCHEMBL7058438 1.00 TSHR (0.67) TSHRLMNANFKB1PMP22ABCC4
Propene SCHEMBL7057263 1.00 TSHR (0.67) TSHRLMNANFKB1PMP22ABCC4
Propene SCHEMBL7052579 1.00 TSHR (0.67) TSHRLMNANFKB1PMP22ABCC4
Sebacic Acid SCHEMBL7054977 1.00 TSHR (0.67) TSHRLMNANFKB1PMP22ABCC4
Azelaic Acid SCHEMBL4945040 1.00 TSHR (0.67) TSHRLMNANFKB1PMP22ABCC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6639089-B2 Therapy, side effect reduction SODA AROMATIC CO., LTD. 2003-10-28 US claimed
US-20030055105-A1 Anticancer agents, perfumes or foods and drinks containing omega-hydroxyfatty acids SODA AROMATIC CO., LTD. A JAPANESE CORPORATION (JP) 2003-03-20 US claimed
EP-1249236-A1 ANTICANCER AGENTS, PERFUMES OR FOODS AND DRINKS CONTAINING $g(v)-HYDROXYFATTY ACIDS SODA AROMATIC COMPANY, LIMITED (JP) 2002-10-16 EP claimed
US-6639089-B2 Therapy, side effect reduction SODA AROMATIC CO., LTD. 2003-10-28 US disclosed
US-20030055105-A1 Anticancer agents, perfumes or foods and drinks containing omega-hydroxyfatty acids SODA AROMATIC CO., LTD. A JAPANESE CORPORATION (JP) 2003-03-20 US disclosed
EP-1249236-A1 ANTICANCER AGENTS, PERFUMES OR FOODS AND DRINKS CONTAINING $g(v)-HYDROXYFATTY ACIDS SODA AROMATIC COMPANY, LIMITED (JP) 2002-10-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030055105-A1 Anticancer agents, perfumes or foods and drinks containing omega-hydroxyfatty acids ALOX5, ELOVL5, ELOVL3 TSHR 4206/4885LMNA 2101/4885NFKB1 848/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.